Active Ingredient(s):Ixekizumab FDA Approved: * March 22, 2016 Pharm Company: *ELI LILLY AND CO Category:Immune System
Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.
The most common side effects include upper respiratory infections, injection site reactions and fungal (tinea) infections.
The drug was developed by Eli Li...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion